Bioscience Chapter Database :: 3657 Chapters Now Online

Chapter category: Surgery

Staging Systems to Predict Survival in Hepatocellular Carcinoma

This chapter appears in the following book:

Recent Advances in Liver Surgery

Edited by: Renzo Dionigi
ISBN: TBA
» Get more information about this book at landesbioscience.com «

Chapter authors:
Sonia Pascual and Miguel Pérez-Mateo


[+] view image
There has been a considerable controversy regarding which is the best prognostic staging system to predict survival in patients with cirrhosis and hepatocellular carcinoma (HCC). Several prognostic models have been developed in the recent years but none has been widely accepted. The staging systems developed by European groups are the French model (GRETCH, Groupe d´Etude de Traitement du Carcinoma Hepatocellulaire), the Barcelona Clinic Liver Cancer classification (BCLC), the Cancer Liver Italian Program classification (CLIP) and the Vienna Survival Model for HCC (VISUM‑HCC). The Asiatic staging systems are: Okuda score, JIS score (Japan Integrated Staging), CUPI (Chinese University Prognosis Index) and Tokyo score. The lack of consensus is in part related to the heterogeneity of models because have been developed in different parts of the world, with different population characteristics and using different variables. Factors that may affect the prognosis of the patients with HCC include tumour stage at diagnosis, physical status of the patient, residual liver function and the therapeutic modality. In order to best assessing the prognosis of patients with HCC it is recommended that the staging systems take into account all of these variables. Most of the prognostic staging systems for HCC use a combination of factors related to liver function, such as presence of ascites, levels of albumin, bilirubin, Child‑Pugh score and others related to the tumour characteristics including portal vein thrombosis, alfa‑fetoprotein (AFP), size, number of lesions and distribution, morphology and TNM (Tumour, Nodule, Metastasis) stage.rnAll available staging systems have demonstrated to be useful in predicting survival but only a few have been externally validated. CLIP, BCLC and JIS staging systems are the most extended and validated. Moreover, BCLC and CLIP have been supported by relevant scientific societies. The BCLC model includes treatment, which is a relevant aspect to consider in these patients and is not included in the other prognostic systems. Until we have more information and considering all of these aspects, probably BCLC should be the preferred staging system.

Sonia Pascual
Unidad Hepática. Hospital General Universitario de Alicante, C/Pintor Baeza s/n, Alicante

Miguel Pérez-Mateo

» Access chapter for $19



Additional chapters from this book:

Transection Techniques in Liver Surgery

Luigi Boni, Gianlorenzo Dionigi, Mario Diurni, and Renzo Dionigi

The main problem which is experienced during liver resection still remains the bleeding control in course of parenchymal division. Over the past decades several techniques such as crush‑clamp, u...

Staging Algorithms for Patients with HCC and Prognostic Indicators

Christos S. Georgiades

Assigning a specific prediction of survival to any patient with HCC is difficult under the best of circumstances. The nature of the disease, the underlying liver function, the performance status of th...

Loco-regional Ablative Therapies for Colorectal Metastases

Ricardo Lencioni, Laura Crocetti and Dania Cioni

During the past decade, several methods for local ablation of hepatic colorectal metastases have been developed and clinically tested. Among these methods, radiofrequency (RF) ablation is currently es...

Liver Surgery: A Historical Account

Renzo Dionigi, Giulio Carcano, Gianlorenzo Dionigi and Francesca Rovera

This introductory article, which includes a list of references for the interested reader, reviews the accomplishments of the past, on which twenty‑first‑century surgery of the liver depend...

Resection of Noncolorectal Cancer Liver Metastases

Cristina R. Ferrone and Kenneth K. Tanabe

The liver remains second only to the regional lymph nodes as the most common site of metastases from gastrointestinal tract malignancies. Other primary tumors outside of the gastrointestinal tract als...

Liver Surgery: A Historical Account

Renzo Dionigi

This introductory article, which includes a list of references for the interested reader, reviews the accomplishments of the past, on which twenty‑first‑century surgery of the liver depend...

Resection of Noncolorectal Cancer Liver Metastases

Cristina R. Ferrone and Kenneth K. Tanabe

The liver remains second only to the regional lymph nodes as the most common site of metastases from gastrointestinal tract malignancies. Other primary tumors outside of the gastrointestinal tract als...

Sepsis after Liver Resection: Predisposition, Clinical Relevance and Synergism with Liver Dysfunction

Gennaro Nuzzo, Ivo Giovannini, Felice Giuliante, Francesco Ardito and Carlo Chiarla

Liver resection, compared with other abdominal operations, is characterized by greater predisposition to septic complications. This may be explained by several factors, including the major role of the...

Preoperative Portal Vein Embolization for Hepatocellular Carcinoma

Taku Aoki, Hiroshi Imamura, Takuya Hashimoto, Norihiro Kokudo and Masatoshi Makuuchi

Preoperative portal vein embolization (PVE) has been introduced to increase the safety of major hepatic resection for hepatocellular carcinoma (HCC). PVE induces atrophy of the embolized portion of th...

Intraoperative Ultrasonic Examination in Liver Surgery

Junichi Arita, Norihiro Kokudo, Keiji Sano and Masatoshi Makuuchi

The safety of liver surgery has improved dramatically over the course of a few decades through the development of intraoperative ultrasonography, an imaging modality that is currently indispensable fo...

Genetics of Hepatocellular Carcinoma

Andreas Teufel

Hepatocellular carcinoma (HCC) is among the most common malignancies worldwide. At present, approximately 550 000 new patients are diagnosed with HCC each year worldwide. However, regional diffe...

Hepatocyte Transplantation: A New Approach to Treat Liver Disorders

Javed Akhter, Loreena A Johnson and David L Morris

As demand for liver transplantation increases, hepatocyte transplantation will play an increasingly important role in the clinic. Clinically, hepatocyte transplantation has already shown its potential...

Vascular Embolotherapy in Hepatocellular Carcinoma

Saad M. Ibrahim, Gianpaolo Carrafiello, Robert J. Lewandowski, Robert K. Ryu, Kent T. Sato , Reed A. Omary and Riad Salem

Treatment options for hepatocellular carcinoma, that cannot be resected or ablated, are based on trans‑arterial techniques. These include drug delivery in the form of traditional chemoembolizati...

Staging Systems to Predict Survival in Hepatocellular Carcinoma

Sonia Pascual and Miguel Pérez-Mateo

There has been a considerable controversy regarding which is the best prognostic staging system to predict survival in patients with cirrhosis and hepatocellular carcinoma (HCC). Several prognostic mo...

One Liver for Two: Split and Living Donor Liver Transplantation for Adult and Pediatric Patients

B. Gridelli, S. Gruttadauria, A. Luca, M. Spada, R. Volpes, W. Marsh and A. Marcos

The dramatic gap between need and availability of grafts for patients on liver transplantation waiting lists has prompted some of the most advanced technical evolutions in transplantation surgery. The...

Response Evaluation Criteria in Hepatocellular Carcinoma (Moving beyond the Recist)

Carlo Fugazzola, Gianpaolo Carrafiello, Chiara Recaldini, Elena Bertolotti, Tamara Cafaro, Maria Gloria Angeretti, Paolo Nicotera and Domenico Lumia

To assess the clinical success of percutaneous minimally invasive therapies for HCC, conventional anatomical imaging based upon size criteria alone (WHO and RECIST) is not sufficient; therefore, addit...

Perioperative Blood Transfusion in Hepatocellular Carcinomas

Gianlorenzo Dionigi, Salvatore Cuffari, Giovanni Cantone, Alessandro Bacuzzi and Renzo Dionigi

Allogeneic blood transfusion during liver resection for malignancies has been associated with an increase incidence of different types of complications: infectious complications, tumor recurrence, dec...

Inferior Vena Cava Resection for Infiltrating Hepatic Malignancy

Gabriele Piffaretti, Gianlorenzo Dionigi, Matteo Tozzi, Patrizio Castelli and Renzo Dionigi

Liver tumors with involvement of the inferior vena cava (IVC) may demand the combined resection of the liver and IVC. This approach, even if it has become common for hepatic malignancies involving the...

Liver Transplantation in HIV‑Infected Individuals

Paolo Antonio Grossi

Several recent reports have shown that end‑stage liver disease is the leading cause of death among HIV‑infected persons in the highly active antiretroviral therapy (HAART) era. Until a few...

Second Messenger Systems in Planaria

Scott M. Rawls

Second messengers are the cellular currency of information transfer. These signaling molecules, along with their related pathways, mediate the acute effects of drugs and the changes in neural plastici...

Percutaneous Treatment of Surgical Bile Duct Injury

Gianpaolo Carrafiello , Domenico Laganà, Monica Mangini, Federico Fontana, Massimiliano Dizonno, Andrea Ianniello, Elisa Cotta, Riad Salem and Carlo Fugazzola

Surgical bile duct injury (SBDI) is one of the most serious complications of hepato‑biliary surgery and liver transplantation. Regardless of the improvements in surgical techniques in recent yea...

Aggressive Surgery for Hepatocellular Carcinoma with Vascular and/or Biliary Involvement

Tsuyoshi Sano and Yuji Nimura

In patients with advanced hepatocellular carcinoma (HCC) presenting with vascular and/or biliary invasion, major hepatectomy is often indicated for curative resection. In HCC patients with portal vein...

Sequential Arterial and Portal Vein Embolization before Right Hepatectomy in Patients with Cirrhosis and Hepatocellular Carcinoma

Jacques Belghiti, Béatrice Aussilhou and Valérie Vilgrain

Major hepatectomy for large HCC in patients remains a crucial procedure due to the possibility of a low regeneration of the future liver remnant (FLR). It has been demonstrated that preoperative porta...

Vascular Isolation Techniques in Liver Resection

Jacques Belghiti, Safi Dokmak and Catherine Paugam-Burtz

During liver resection, various techniques of hepatic vascular control have been proposed to minimize the intraoperative blood losses. They include the isolated occlusion of the hepatic inflow (pedicu...

Surgical Strategies and Technique for Hilar Cholangiocarcinoma

Tsuyoshi Sano and Yuji Nimura

Hepatobiliary resection for hilar cholangiocarcinoma (HC) remains a technically demanding procedure, calling for a high level of expertise in biliary and hepatic surgery. Treatment strategy for HC inc...

Radiological Intervention for Treatment of Complications after Liver Transplantation

Giovanni Gandini, Maria Carla Cassinis, Dorico Righi, Andrea Doriguzzi-Breatta, Maria Cristina Martina and Maria Antonella Ruffino

Orthotopic liver transplantation (OLT) is a widely accepted treatment for end‑stage chronic liver disease and severe liver failure. Despite improvement in survival due to advances in surgical te...

Virtual Liver Surgery: Computer-assisted operation planning in 3D liver model

Hauke Lang, Milo Hindennach, Arnold Radtke and Heinz Otto Peitgen

Ongoing development in CT imaging-based computer assistance has enabled an optimal visualization of the intrahepatic vascular branching in a virtual 3D liver model providing an individual territorial ...

Current Role of Laprascopic Surgery for Liver Malignancies

Andrew A. Gumbs and Brice Gayet

Since the first report of a laparoscopic liver resection, laparoscopic hepatic resection has become increasingly more common in the surgical treatment of both benign and malignant tumors. The minimall...

Partial Hepatectomy after Liver Transplantation: Inclusion Criteria, Timing of Surgery and Outcome

Franco Filipponi and Franco Mosca

Partial hepatectomy is uncommon after liver transplantation (LT) but can be a graft saving procedure in selected cases. Inclusion criteria, outcome and timing of a single Center series are here presen...


SIGN IN

Email:


Password:


lost password?




[ Home | Authors | Editors | Custom Books | Chapter Reprints | Subscribe | Contact | Biotoons ]